Patient with lymphangioleiomyomatosis and microscopic polyangiitis
Main Article Content
Article Sidebar
Published
December 29, 2017
Marcos Vázquez
Ana Soskin
Rafael Flor
Sonia Sanchez
Luis Montaner
Margarita Duarte
Abstract
Lymphangioleiomyomatosis is a rare disease, first described in 1918 by Lutenbacher in a patient with tuberous sclerosis. It belongs to the group of interstitial lung diseases of unknown etiology and predominantly affects premenopausal women.
How to Cite
1.
Vázquez M, Soskin A, Flor R, Sanchez S, Montaner L, Duarte M. Patient with lymphangioleiomyomatosis and microscopic polyangiitis. Rev. parag. reumatol. [Internet]. 2017 Dec. 29 [cited 2026 Sep. 19];3(2):65-6. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/79
Downloads
Download data is not yet available.
Article Details
References
(1) Belda FJ, Lloréns J. Ventilación mecánica en anestesia. 1ªed. Madrid: Aran Ediciones, 1999;p:315-327.
(2) Bonetti F, Chiodera P. Lymphangioleiomyomatosis and tuberoussclerosis: whereistheborder?EurRespir J 1996;9:399-401.
(3) Antón E, Casanova A, Xaubet A, Román A, Villena V, Montero MC, et al. Lymphangioleiomyomatosis: a study of 72 patients from the Spanish Registry. Sarcoidosis, vasculitis and diffuselungdiseases.
Sarcoidosis VascDiffuseLungDis 2009;26(2);85-91.
(4) Matsui K, Takeda K, Yu ZX, Zu-Xi Y, Travis WD, Moss J, Ferrans VJ. R ole foractivationofmatrixmetallo-proteinases in thepathogenesis ofpulmonarylymphangioleiomyomatosis. ArchPatholLabMed 2000;124: 267-75.
(5) Moss J, De Castro R, Patronas NJ, et al. Meningiomas in lymphangioleiomyomatosis. JAMA 2001;286:1879-1881.
(6) Tanaka H, Imada A, Morikawa T, Shibusa T, Satoh M, Sekine K et al. Diagnosis ofpulmonarylymphangioleiomyomatosisby HMB45 in surgicallytreatedspontaneouspneumothorax. EurRespir J 1995; 8:1879-82.
(7) S.K. Frankel,G.P. Cosgrove,A. Fischer,R.T. Meehan,K.K. Brown U pdate in the diagnosis and management of pulmonary vasculitis C hest, 129 (2006), pp. 452-465.
(8) M.I. Schwarz,K.K. Brown Small vessels vasculitis of the lung Thorax, 55 (2000), pp. 502-510.
(9) Bissler JJ, McCormack FX, Young LR, Elwing JM, ChuckG, Leonard JM, et al. Sirolimusforangiomyolipoma intuberoussclerosiscompl exorlymphangioleiomyomotosis.N Engl J Med 2008;358(2):140-15.
(2) Bonetti F, Chiodera P. Lymphangioleiomyomatosis and tuberoussclerosis: whereistheborder?EurRespir J 1996;9:399-401.
(3) Antón E, Casanova A, Xaubet A, Román A, Villena V, Montero MC, et al. Lymphangioleiomyomatosis: a study of 72 patients from the Spanish Registry. Sarcoidosis, vasculitis and diffuselungdiseases.
Sarcoidosis VascDiffuseLungDis 2009;26(2);85-91.
(4) Matsui K, Takeda K, Yu ZX, Zu-Xi Y, Travis WD, Moss J, Ferrans VJ. R ole foractivationofmatrixmetallo-proteinases in thepathogenesis ofpulmonarylymphangioleiomyomatosis. ArchPatholLabMed 2000;124: 267-75.
(5) Moss J, De Castro R, Patronas NJ, et al. Meningiomas in lymphangioleiomyomatosis. JAMA 2001;286:1879-1881.
(6) Tanaka H, Imada A, Morikawa T, Shibusa T, Satoh M, Sekine K et al. Diagnosis ofpulmonarylymphangioleiomyomatosisby HMB45 in surgicallytreatedspontaneouspneumothorax. EurRespir J 1995; 8:1879-82.
(7) S.K. Frankel,G.P. Cosgrove,A. Fischer,R.T. Meehan,K.K. Brown U pdate in the diagnosis and management of pulmonary vasculitis C hest, 129 (2006), pp. 452-465.
(8) M.I. Schwarz,K.K. Brown Small vessels vasculitis of the lung Thorax, 55 (2000), pp. 502-510.
(9) Bissler JJ, McCormack FX, Young LR, Elwing JM, ChuckG, Leonard JM, et al. Sirolimusforangiomyolipoma intuberoussclerosiscompl exorlymphangioleiomyomotosis.N Engl J Med 2008;358(2):140-15.
Section
LETTERS TO THE EDITOR
How to Cite
1.
Vázquez M, Soskin A, Flor R, Sanchez S, Montaner L, Duarte M. Patient with lymphangioleiomyomatosis and microscopic polyangiitis. Rev. parag. reumatol. [Internet]. 2017 Dec. 29 [cited 2026 Sep. 19];3(2):65-6. Available from: https://www.revista.spr.org.py/index.php/spr/article/view/79